| The board of Jubilant Pharmova at its meeting held on 12 October 2026 has approved issuance of up to 80,000 fully paid-up, rupee denominated, secured / unsecured, listed, rated, redeemable and transferable non-convertible debentures of face value of Rs 1,00,000 each, aggregating up to Rs 800 crore, on a private placement basis, in one or more tranches, subject to applicable laws and regulatory approvals, if any. |